Arbor Biotechnologies
Christopher Russo currently serves as a Senior Research Associate at Arbor Biotechnologies, focusing on the development of programmable DNA editors for curative genetic medicines. Previously, Christopher held senior research associate positions at Skyhawk Therapeutics and Fulcrum Therapeutics, where efforts were directed at addressing genetically defined diseases and advancing drug discovery. Prior experiences include a role as a Senior Research Associate at Foundation Medicine, specializing in genomic profiling assays for cancer, and research technologist positions at Massachusetts General Hospital, contributing to studies on movement disorders and genetic research. Christopher Russo is pursuing a Master of Arts in Biotechnology at Harvard Extension School, having earned a Bachelor of Science in Biobehavioral Health from Penn State University.
This person is not in the org chart
Arbor Biotechnologies
2 followers
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.